WallStreetZenWallStreetZen

NASDAQ: IMMX
IMMIX Biopharma Inc Stock Ownership - Who owns IMMIX Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have IMMIX Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ilya M. RachmanCEO and Chairman2025-06-182,178$2.30
$5.00kBuy
Gabriel S. MorrisCFO2025-06-182,225$2.28
$5.07kBuy
Jason HsuDirector2024-12-2340,000$2.19
$87.68kBuy
Jason HsuDirector2024-12-207,700$2.17
$16.68kBuy
Jason HsuDirector2024-08-228,100$2.25
$18.23kBuy
Jason HsuDirector2024-08-2115,000$2.23
$33.39kBuy
Carey NgDirector2024-08-1610,000$1.86
$18.60kBuy
Jason HsuDirector2024-07-246,000$2.15
$12.88kBuy
Jason HsuDirector2024-07-183,200$2.08
$6.64kBuy

1 of 1

IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMMX insiders and whales buy or sell their stock.

IMMX Shareholders

What type of owners hold IMMIX Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky11.63%3,241,076$8.59MInsider
Ilya M. Rachman4.08%1,138,437$3.02MInsider
Carey Ng3.75%1,045,221$2.77MInsider
Jason Hsu3.38%943,000$2.50MInsider
Vladimir P. Torchilin3.25%905,200$2.40MInsider
Sean Senn3.23%899,800$2.38MInsider
Bleichroeder LP3.05%850,000$2.25MInstitution
Cable Car Capital LP2.80%779,358$2.07MInstitution
Vanguard Group Inc2.51%698,537$1.85MInstitution
Gabriel S. Morris1.12%312,200$827.33kInsider

1 of 3

IMMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMMX10.47%31.45%Net BuyingNet Buying
IMUX42.22%16.57%Net BuyingNet Buying
ZURA51.74%48.26%Net Selling
QNCX11.26%88.74%Net BuyingNet Buying
IGMS29.64%54.28%Net SellingNet Selling
View Top Biotech Stocks

IMMIX Biopharma Stock Ownership FAQ

Who owns IMMIX Biopharma?

IMMIX Biopharma (NASDAQ: IMMX) is owned by 10.47% institutional shareholders, 31.45% IMMIX Biopharma insiders, and 58.08% retail investors. Yekaterina Chudnovsky is the largest individual IMMIX Biopharma shareholder, owning 3.24M shares representing 11.63% of the company. Yekaterina Chudnovsky's IMMIX Biopharma shares are currently valued at $9.37M.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.